Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap |
| Investment focus | Equity, Europe, Social/Environmental |
| Fund size | CHF 225 m |
| Total expense ratio | 0.17% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in CHF) | 14.90% |
| Inception/ Listing Date | 10 November 2017 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Ossiam |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH, Luxembourg Branch |
| Investment Advisor | |
| Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
| Revision Company | Deloitte Audit S.A.R.L |
| Fiscal Year End | 31 December |
| Swiss representative | CACEIS Bank, Montrouge, Zurich Branch / Switzerland, Bleicherweg |
| Swiss paying agent | CACEIS Bank, Montrouge, Zurich Branch / Switzerland, Bleicherweg |
| Germany | Unknown |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | No UK Reporting |
| Indextype | Total return index |
| Swap counterparty | JPMorgan Chase & Co |
| Collateral manager | State Street Bank |
| Securities lending | No |
| Securities lending counterparty |
| AstraZeneca | 6.06% |
| Novartis | 5.30% |
| Roche Holding | 5.26% |
| Nestle | 4.41% |
| HSBC Holdings | 3.71% |
| Novo Nordisk | 3.16% |
| Cie Financiere Richemont | 2.38% |
| Unilever Plc | 2.32% |
| Rolls-Royce Holdings | 2.29% |
| GSK | 2.23% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00CHF | 0.00CHF | View offer* | |
| 0.00CHF | 0.00CHF | View offer* |
| YTD | +5.12% |
| 1 month | +3.18% |
| 3 months | +7.67% |
| 6 months | +11.09% |
| 1 year | +7.28% |
| 3 years | +27.09% |
| 5 years | +43.36% |
| Since inception (MAX) | +53.00% |
| 2025 | +11.17% |
| 2024 | +9.93% |
| 2023 | +6.75% |
| 2022 | -12.10% |
| Volatility 1 year | 14.90% |
| Volatility 3 years | 12.98% |
| Volatility 5 years | 14.32% |
| Return per risk 1 year | 0.49 |
| Return per risk 3 years | 0.64 |
| Return per risk 5 years | 0.52 |
| Maximum drawdown 1 year | -18.43% |
| Maximum drawdown 3 years | -18.43% |
| Maximum drawdown 5 years | -22.38% |
| Maximum drawdown since inception | -34.37% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | OP4E | - - | - - | - |
| Euronext Paris | EUR | OP4E | OP4E FP IOP4E | OP4E.PA IOP4E | |
| SIX Swiss Exchange | EUR | OP4E | OP4E SX IOP4E | OP4E.S IOP4E | |
| XETRA | EUR | OP4E | OP4E GY IOP4E | OP4E.DE IOP4E |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| Amundi S&P Eurozone Climate Paris Aligned UCITS ETF Acc | 2,623 | 0.20% p.a. | Accumulating | Full replication |
| Amundi MSCI Europe ESG Broad Transition UCITS ETF - EUR (C) | 2,503 | 0.12% p.a. | Accumulating | Full replication |
| iShares MSCI EMU Paris-Aligned Climate UCITS ETF EUR (Acc) | 1,291 | 0.15% p.a. | Accumulating | Full replication |
| L&G MSCI Europe Climate Pathway UCITS ETF EUR Accumulating ETF | 1,287 | 0.10% p.a. | Accumulating | Full replication |
| Amundi MSCI EMU ESG Broad Transition UCITS ETF Acc | 1,235 | 0.12% p.a. | Accumulating | Full replication |